A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients
| 适应症 | Asthma in Children |
|---|---|
| 分期 | 不适用 |
| 申办方 | Mayo Clinic |
| 状态 | 已完成 |
| 受试者人数 | 49 人 |
| 干预（药物） | AsthmaTuner, Asthma-Guidance and Prediction System |
| 开始日期 | 2023年12月5日 |
| 完成日期 | 2025年6月5日 |
| 结果公布日 | 2026年7月22日 |
摘要
The main purpose of this study is to look at whether clinicians and their patients with asthma can satisfactorily perform remote asthma management at home (not visiting clinic) by using an artificial intelligence tool called Asthma-Guidance and Prediction System combined with a home monitoring device called AsthmaTuner.
Change in Satisfaction of Asthma Care
| Pediatric Asthma Intervention Group | 4.5 ± 0.67 score on a scale |
|---|---|
| Pediatric Asthma Control Group | 4.6 ± 0.71 score on a scale |
| Clinician Control Group | 4.3 ± 0.71 score on a scale |
| Clinician Intervention Group | 3.7 ± 0.95 score on a scale |
| Pediatric Asthma Intervention Group | 4.3 ± 1.39 score on a scale |
| Clinician Control Group | 4.2 ± 0.84 score on a scale |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Developing a Childhood Asthma Risk Passive Digital Marker — Indiana University
- A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With C — Chiesi Farmaceutici S.p.A.
- A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to — Hoffmann-La Roche
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Cortic — Hoffmann-La Roche
- Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Sev — AstraZeneca
- Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma — ARS Pharmaceuticals, Inc.